Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Conformal Radiation Therapy for Pediatric Patients With Localized Ependymoma, Chemotherapy Prior to Second Surgery for Incompletely Resected Ependymoma and Observation for Completely Resected, Differentiated, Supratentorial Ependymoma

NCT00027846 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00027846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00027846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Conformal Radiation Therapy for Pediatric Patients With Localized Ependymoma, Chemotherapy Prior to Second Surgery for Incompletely Resected Ependymoma and Observation for Completely Resected, Differentiated, Supratentorial Ependymoma
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2003
Completion date
March 31, 2016
Enrollment
378 (actual)
Sites
165

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, central nervous system tumor